IQWiG in dialogue

The Institute launched its programme "IQWiG in dialogue" in May 2008. The aim is to offer representatives from science, industry and IQWiG the opportunity for scientific and technical discussion on various topics related to the work of the Institute.

Presentations from previous "IQWiG in dialogue" Events

2023: How can health economic evaluations be assessed?

2021: Handling of scales in benefit assessments

2019: Do causal models provide proof of causal connections?

2018: Do the new “estimand” strategies compromise the standards of benefit assessments?

2017: The IQWiG Methods in an International Context

2016: “Do we need stricter criteria for assessing evidence?”

2015: „How confirmatory is HTA?“

2014: Benefit assessment in studies with allowed treatment switching

2013: Importance of approval status for the benefit assessment

2012: Uncertainty in benefit assessments

2011: Heterogeneity in benefit assessments

2010: The evaluation of clinical relevance in benefit assessments

2009: Assessing benefit without considering harm?

2008: Assessing benefit and replication of study results

Print page